Intimate cleansing products are designed for different application areas, rinse-off formats, and needs around the mucosal-adjacent skin. Greater foam or stronger oil removal does not automatically mean better product performance. SLS, sodium lauryl sulfate, and SLES, sodium laurel ether sulfate, are widely recognized anionic surfactants that can remove sebum and soil effectively. However, their performance and sensory profile must be evaluated within the complete formula, including pH, builders, thickeners, fragrance, and rinse conditions.
Amino-acid surfactants are commonly formed by reacting an amino-acid amphiphile with a strong-acid neutralizer. Examples include sodium cocoyl glutamate, sodium cocoyl glycinate, and sodium lauroyl glutamate. Their hydrophilic and hydrophobic regions influence micelle formation, soil encapsulation, foam, and rinsing. Compared with sulfate-based surfactants, these systems may create a different balance of cleansing, viscosity, and post-rinse residue. The result depends on the specific raw material, active concentration, and formula architecture.
The sensory difference is rarely driven by one ingredient alone. Some amino-acid surfactant systems show a lower irritation tendency under controlled testing, but the final experience also depends on charge modifiers, humectants, polymers, fragrance, pH, and frequency of use. Excess surfactant or incomplete rinsing may contribute to tightness, slipperiness, or a repeated-cleansing feeling. Too little cleansing activity can leave a less fresh after-feel. Buyers should request comparable foam, residue, rinse-off time, and sensory data using consistent test methods.
During development, first define the product format and measurable performance targets: rinse-off or leave-on positioning, target foam level, post-rinse slip, fragrance status, and viscosity requirements at approximately 25°C and 40°C. Screen surfactant ratios, pH, and electrolyte tolerance before scaling. Then conduct accelerated stability, preservative challenge testing, and packaging compatibility. For products intended for mucosal-adjacent use, include an appropriate safety-evaluation plan rather than relying only on ingredient naming or a “natural-origin” claim.
Cost and supply reliability should be assessed at the same time as sensory performance. Amino-acid surfactants may involve different pricing, availability, thickening behavior, and minimum order quantities than SLS or SLES. A staged process—from laboratory evaluation to pilot batches and commercial production—helps control reformulation risk. For export programs, buyers should also confirm ingredient listing, labeling obligations, responsible-party requirements, and adverse-event procedures in the destination market before finalizing the product brief.
For the United States, cosmetic labeling and manufacturing compliance depend on the sales channel, product category, safety assessment, and applicable MoCRA requirements. In China, filing, efficacy-claim substantiation, and quality-management requirements should be reviewed separately. Avoid claims such as treating infections, inflammation, or gynecological conditions unless supported within the applicable regulatory framework. COAs, MSDS, stability data, and challenge-test reports should match the formula version and batch, and key changes should trigger reassessment.
BioCera Labs is based in Shanghai’s Oriental Beauty Valley, with more than 10,000 square meters of production space, eight automated lines, a 100,000-class clean workshop, and an EDI pure-water system. The company supports OEM, ODM, and OBM development for facial skincare and women’s intimate care. BFS single-dose filling and multi-piece kits enable differentiated formats. Typical MOQs are approximately 1,000–5,000 units for mature formulas and 3,000–10,000 units for customized formulas, with batch documentation available. Visit bioceralabs.com for further information.